Intermittent inotropes for advanced heart failure: Inquiring minds want to know: Editorial

American Heart Journal

Volumn 138, Issue 2 I, 1999, Pages 191-192

  Silver, M A ^a  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG INDICATION; EDITORIAL; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; OUTPATIENT; PRIORITY JOURNAL;

EID: 0032776888     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70098-0     Document Type: Editorial

References (3)

1. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986;74(suppl II):II-38.
2. Hatzizacharias A, Makris T, Krespi P, et al. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Am Heart J 1999;138:241-6.
3. Oliva F, Latini R, Politi A, et al. Intermittent 6-month low dose dobutamine infusion in severe heart failure: DICE Multicenter trial. Am Heart J 1999;138:247-53.